Is acetylsalicylic acid use in cats contraindicated or limited indicated?

Said Cafer; Bengü Bilgiç; Mehmet Erman Or

doi:10.59400/jts.v2i2.1486

Said Cafer Department of Internal Medicine, Faculty of Veterinary Medicine, Istanbul University-Cerrahpaşa, Istanbul 34315, Turkey
Bengü Bilgiç Department of Internal Medicine, Faculty of Veterinary Medicine, Istanbul University-Cerrahpaşa, Istanbul 34315, Turkey
Mehmet Erman Or Department of Internal Medicine, Faculty of Veterinary Medicine, Istanbul University-Cerrahpaşa, Istanbul 34315, Turkey

Ariticle ID: 1486

1 Views, 0 PDF Downloads

DOI: https://doi.org/10.59400/jts.v2i2.1486

Keywords: aspirin; NSAID’s; ulcer; salicylate; thromboembolism; toxicity

Abstract

Acetylsalic acid, (Aspirin^®) is a nonsteroidal anti-inflammatory drug (NSAID) widely used in human and veterinary medicine, especially for its analgesic and antithrombotic effects, mainly in the prevention of cardiovascular complications and in the treatment of various diseases. Aspirin^® can not be metabolized in cats because they do not have the enzyme glucuronyl transferase. For this reason, it has a long half-life and a narrow dose range. High dose administration in cats may cause serious toxicity in the liver. Acetylsalicylic acid is known to cause gastric ulcers associated with decreased prostaglandin levels. For these reasons, it is considered toxic to cats. But it also has antipyretic, analgesic, anti-inflammatory and antithrombotic properties. It is indicated for use alone or in combination with other antithrombotic drugs in the treatment and prophylaxis of thrombus formation resulting from cardiovascular diseases. This review aims to examine the indicated and contraindicated areas of use of Aspirin^®, which is widely considered toxic in cats.

References

[1] Cathcart CJ, Brainard BM, Reynolds LR, et al. Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats. Journal of Veterinary Emergency and Critical Care 2011; 22(1): 99-106. https://doi.org/10.1111/j.1476-4431.2011.00681.x.

[2] Khan SA, McLean MK. Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats. Veterinary Clinics of North America Small Animal Practice 2012; 42(2): 289-306. https://doi.org/10.1016/j.cvsm.2012.01.003.

[3] Fuentes VL, Abbott J, Chetboul V, et al. ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. Journal of veterinary internal medicine 2020; 34(3): 1062-1077. https://doi.org/10.1111/jvim.15745.

[4] Vane JR and Botting RM. The mechanism of action of aspirin. Thrombosis research 2003; 110(5-6): 255-258. https://doi.org/10.1016/s0049-3848(03)00379-7.

[5] Albo AG, Nebbia C. Incidence of Poisonings in Domestic Carnivores in Italy. LVII Annual Meeting of the Italian Society for Veterin Ary Sciences (SISVET); 2003 Ischia; Veterinary Research Communications; 2004. p.83-88.

[6] De Santis F, Boari A, Dondi F, et al. Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease. Animals 2022; 12(3): 1-29. https://doi.org/10.3390/ani12030262.

[7] Lautz LS, Jeddi MZ, Girolami F, et al. Metabolism and pharmacokinetics of pharmaceuticals in cats (Felix sylvestris catus) and implications for the risk assessment of feed additives and contaminants. Toxicology Letters 2020; 338: 114-127. https://doi.org/10.1016/j.toxlet.2020.11.014.

[8] Shrestha B, Reed JM, Starks PT, et al. Evolution of a Major Drug Metabolizing Enzyme Defect in the Domestic Cat and Other Felidae: Phylogenetic Timing and the Role of Hypercarnivory. PloS ONE 2011; 6(3): 1-11 . https://doi.org/10.1371/journal.pone.0018046.

[9] Court MH. Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms. The Veterinary clinics of North America Small animal practice 2013; 43(5): 1039–1054. https://doi.org/10.1016/j.cvsm.2013.05.002.

[10] Lynch A, Shaw H and Milton GW. Effect of aspirin on gastric secretion. GUT 1964; 5(3): 230-236. https://doi.org/10.1136/gut.5.3.230.

[11] Montinari MR, Minelli S, De Caterina R. The first 3500 years of aspirin history from its roots – A concise summary. Vascular Pharmacology 2018; 113: 1-8. https://doi.org/10.1016/j.vph.2018.10.008

[12] Gupta RC. Veterinary Toxicology: Basic and Clinical Principals, 3rd ed. London, UK: Academic Press of Elsevier; 2018.

[13] Stone E. XXXII. An account of the success of the bark of the willow in the cure of agues. In a letter to the Right Honourable George Earl of Macclesfield, President of R. S. from the Rev. Mr. Edward Stone, of Chipping-Norton in Oxfordshire. Philosophical Transactions of the Royal Society of London 1763; 53: 195-200. https://doi.org/10.1098/rstl.1763.0033

[14] Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101(10): 1206-1218. https://doi.org/10.1161/01.CIR.101.10.1206.

[15] Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New biology, 1971; 231(25): 232-235. https://doi.org/10.1038/newbio231232a0

[16] Karademir Ü, Boyacıoğlu M. Nonsteroidal Antiinflamatuvar İlaçların Kedi ve Köpeklerde Etkili ve Güvenli Kullanımı. Journal of Faculty of Veterinary Medicine, Erciyes University 2014; 11(2): 137-143.

[17] Lascelles BDX, Court MH, Hardie EM, et al. Nonsteroidal anti-inflammatory drugs in cats: a review. Veterinary Anaesthesia and Analgesia 2007; 34: 228-250. https://doi.org/10.1111/j.1467-2995.2006.00322.x.

[18] Maddison JE, Page SW and Church DB. Small Animal Clinical Pharmacology, 2nd ed. Edinburgh: Saunders Elsevier; 2008.

[19] Whalan JE. A Toxicologist’s Guide to Clinical Pathology in Animals: Hematology, Clinical Chemistry, Urinalysis, Switzerland: Springer International; 2015.

[20] Wallig MA, Haschek WM, Rousseaux CG, et al. Fundamentals of Toxicologic Pathology, 3rd ed. London: Academic Press, Elsevier; 2018.

[21] Penny RH, Carlisle CH, Prescott CW, et al. Effects of aspirin (acetylsalicylic acid) on the haemopoietic system of the cat. The British veterinary journal 1967; 123(4): 154-161. https://doi.org/10.1016/s0007-1935(17)40054-6.

[22] D’Agati V. Does aspirin cause acute or chronic renal failure in experimental animals and in humans?. American Journal of Kidney Diseases 1996; 28(1): S24-S29. https://doi.org/10.1016/S0272-6386(96)90565-X.

[23] Konturek SJ, Radecki T, Brzozowski T, et al. Aspirin-induced gastric ulcers in cats. Prevention by prostacyclin. Digestive diseases and sciences 1981; 26(11): 1003-1012. https://doi.org/10.1007/BF01314763.

[24] Bugat R, Thompson MR, Aures D, et al. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology 1976; 71(5): 754-759.

[25] Satoh H, Amagease K and Takeuchi K. The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats. Digestive diseases and sciences 2013; 58(10): 2840-2849. https://doi.org/10.1007/s10620-013-2725-7.

[26] Hansen DG, Aures D and Grossman MI. Histamine augments gastric ulceration produced by intravenous aspirin in cats. Gastroenterology 1978; 74(3): 540-543.

[27] Hansen DF, Aures D and Grossman MI. Comparison of Intravenous and Intragastric Aspirin in Production of Antral Gastric Ulcers in Cats. Proceedings Of The Society For Experimental Biology And Medicine 1980; 164(4): 589-592. https://doi.org/10.3181/00379727-164-40921.

[28] Svanes K, Leiknes KA, Varhaug JE, et al. Aspirin damage to ischemic gastric mucosa in shocked cats. Scandinavian journal of gastroenterology 1979; 14(5): 633-639. https://doi.org/10.3109/00365527909181402.

[29] Feldberg W, Gupta KP, Milton AS, et al. Effect of pyrogen and antipyretics on prostaglandin activity in cisternal c.s.f. of unanaesthetized cats. The Journal of Physiology 1973; 234(2): 279-303. https://doi.org/10.1113/jphysiol.1973.sp010346.

[30] Hardie EM. Management of Osteoarthritis in Cats. Veterinary Clinics of North America: Small Animal Practice 1997; 27(4): 945-953. https://doi.org/10.1016/S0195-5616(97)50088-X.

[31] Lunsford KV, Mackin AJ. Thromboembolic therapies in dogs and cats: an evidence-based approach.T he Veterinary clinics of North America: Small animal practice 2007; 37(3): 579-609. https://doi.org/10.1016/j.cvsm.2007.01.010.

[32] Hogan DF, Fox PR, Jacob K, et al. Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT). Journal of veterinary cardiology: the official journal of the European Society of Veterinary Cardiology 2015; 17(1): S306-S317. https://doi.org/10.1016/j.jvc.2015.10.004.

[33] Bilgic B, Tarhan D, Ekiz B, et al. The effect of pimobendan and enalapril use on blood serum trace element levels in dogs with myxomatous mitral valve disease. Journal of Trace Elements and Minerals 2023, 4: 1-8. https://doi.org/10.1016/j.vph.2018.10.008.

[34] Sedláčková K, Száková J, Načeradská M, et al. Essential microelement (copper, selenium, zinc) status according to age and sex in healthy cats. Acta veterinaria Hungarica 2022; 70(4): 296-304. https://doi.org/10.1556/004.2022.00036.

[35] Rishniw M. How much protection does clopridogrel provide to cats with hypertrophic cardiomyopathy?. Journal of the American Veterinary Medical Association 2024; 1-3. https://doi.org/10.2460/javma.24.04.0269.

[36] Ho KH, Abrams-Ogg AC, Wood RD, et al. Assessment of platelet function in healthy cats in response to commonly prescribed antiplatelet drugs using three point-of-care platelet function tests. Journal of feline medicine and surgery 2017; 19(6): 638-647. https://doi.org/10.1177/1098612X16648182.

[37] Blais MC, Bianco D, Goggs R, et al. Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 3-Defining antithrombotic protocols. Journal of veterinary emergency and critical care 2019; 29(1): 60-74. https://doi.org/10.1111/vec.12795.

[38] Borgeat K, Wright J, Garrod O, et al. Arterial thromboembolism in 250 cats in general practice: 2004-2012. Journal of veterinary internal medicine 2014; 28(1): 102-108. https://doi.org/10.1111/jvim.12249.

[39] Çolakoğlu EÇ, Alihosseini H, Haydardedeoğlu AE. Hipertrofik Kardiyomyopatili Kedilerde Trombosit ve Ortalama Trombosit Hacmi Düzeyleri Erken Emboli Oluşumunu Belirlemede Kullanılabilir mi?. Harran Üniversitesi Veteriner Fakültesi Dergisi 2018; 7(1): 84-88. https://doi.org/10.31196/huvfd.470810.

[40] Greenway CV, Murthy VS. Mesenteric vasoconstriction after endotoxin administration in cats pretreated with aspirin. British journal of pharmacology 1971; 43(2): 259-269.

[41] Hall RC, Hodge RL, Irvine R, et al. The effect of aspirin on the response to endotoxin. The Australian journal of experimental biology and medical science 1972; 50(5): 589-601. https://doi.org/10.1038/icb.1972.52.

[42] Riciotti E, Wangensteen KJ, FitzGerald GA. Aspirin in hepatocellular carcinoma. Cancer Research 2021; 81(14): 3751-3761. https://doi.org/10.1158/0008-5472.CAN-21-0758.

[43] Kim MY, Han YM, Park JM, et al. GI-Safer Aspirin: Sometimes Sugar Coating Helps. Digestive diseases and sciences 2016; 61(8): 2151-2153. https://doi.org/10.1007/s10620-016-4236-9.

[44] Rawlings CA, Farrell RL, Mahood RM. Morphologic changes in the lungs of cats experimentally infected with Dirofilaria immitis: Response to aspirin. Journal of veterinary internal medicine 1990; 4(6): 292-300. https://doi.org/10.1111/j.1939-1676.1990.tb03126.x.

[45] Daş N, Nebioğlu S. Vitamin C aspirin interactions in laboratory animals. Journal of clinical pharmacy and therapeutics 1992; 17(6): 343-346. https://doi.org/10.1111/j.1365-2710.1992.tb01315.x

[46] Dion PD. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. The Veterinary clinics of North America. Small animal practice 1988; 18(1): 79-86. https://doi.org/10.1016/s0195-5616(88)50008-6.

[47] Keimowitz RM, Pulvermacher G, Mayo G, et al. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. Circulation 1993; 88(2): 556-561. https://doi.org/10.1161/01.cir.88.2.556

[48] Hawthorne AB, Mahida YR, Cole AT, et al. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. British journal of clinical pharmacology 1991; 32(1): 77-83. https://doi.org/10.1111/j.1365-2125.1991.tb05616.x.

[49] Clerici B, Cattaneo M. Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review. Journal of cardiovascular development and disease 2023; 10(4): 1-11. https://doi.org/10.3390/jcdd10040137.

[50] Johnston SA, Leib MS, Forrester SD, et al. The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs. Journal of veterinary internal medicine 1995; 9(1): 32-38. https://doi.org/10.1111/j.1939-1676.1995.tb03269.x.

[51] Tarnawski AS, Caves TC. Aspirin in the XXI century: its major clinical impact, novel mechanisms of action, and new safer formulations. Gastroenterology 2004; 127(1): 341-343. https://doi.org/10.1053/j.gastro.2004.05.037

[52] Etscheidt J, Shahien A, Gainey M, et al. Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty. Geriatrics 2020; 5(1): 1-15. https://doi.org/10.3390/geriatrics5010018.